Reference health

Context-Dependent Role of Oxidized Lipids and Lipoproteins in Inflammation

https://doi.org/10.1016/j.tem.2016.11.002
CiteStamped reference-health badge
82/82 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 82 checked references that resolve
resolves10.1016/0891-5849(91)90192-6
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
resolves10.1007/978-90-481-8622-8_8
Lipoprotein Modification and Macrophage Uptake: Role of Pathologic Cholesterol Transport in Atherogenesis
resolves10.2174/138161211795049831
Oxidative Modification of Lipoproteins: Mechanisms, Role in Inflammation and Potential Clinical Applications in Cardiovascular Disease
resolves10.1161/CIRCRESAHA.110.223875
Oxidation-Specific Epitopes Are Danger-Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate Immunity
resolves10.1097/MOL.0b013e328364e85a
Oxidation-specific epitopes as targets for biotheranostic applications in humans
resolves10.1007/s00401-014-1263-5
Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models
resolves10.1016/j.cell.2008.02.043
Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury
resolves10.1038/nri.2016.63
Innate sensing of oxidation-specific epitopes in health and disease
resolves10.1172/JCI4533
Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid–protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins
resolves10.1172/JCI8472
Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity
resolves10.1016/S0022-2275(20)30281-9
Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein
resolves10.1194/jlr.M400496-JLR200
Phosphocholine as a pattern recognition ligand for CD36
resolves10.1038/nm876
Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL
resolves10.1074/jbc.M709006200
Cholesteryl Ester Hydroperoxides Are Biologically Active Components of Minimally Oxidized Low Density Lipoprotein
resolves10.1161/CIRCRESAHA.108.192880
Lipoprotein Accumulation in Macrophages via Toll-Like Receptor-4–Dependent Fluid Phase Uptake
resolves10.1371/journal.pone.0083145
Polyoxygenated Cholesterol Ester Hydroperoxide Activates TLR4 and SYK Dependent Signaling in Macrophages
resolves10.1016/j.jacc.2014.01.055
Release and Capture of Bioactive Oxidized Phospholipids and Oxidized Cholesteryl Esters During Percutaneous Coronary and Peripheral Arterial Interventions in Humans
resolves10.1074/jbc.M209634200
Minimally Modified LDL Binds to CD14, Induces Macrophage Spreading via TLR4/MD-2, and Inhibits Phagocytosis of Apoptotic Cells
resolves10.1038/nature07830
The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
resolves10.1016/j.bbrc.2016.01.126
MD-2 binds cholesterol
resolves10.1126/scisignal.2005860
Toll-like receptor 4 senses oxidative stress mediated by the oxidation of phospholipids in extracellular vesicles
resolves10.1016/j.cyto.2008.07.010
Signalling adaptors used by Toll-like receptors: An update
resolves10.1161/CIRCRESAHA.108.181040
Macrophages Generate Reactive Oxygen Species in Response to Minimally Oxidized Low-Density Lipoprotein
resolves10.1371/journal.pone.0032378
Spleen Tyrosine Kinase Regulates AP-1 Dependent Transcriptional Response to Minimally Oxidized LDL
resolves10.1161/ATVBAHA.111.230847
The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice
resolves10.1007/s00395-016-0535-8
Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression
resolves10.1161/CIRCRESAHA.111.256859
Role of Phospholipid Oxidation Products in Atherosclerosis
resolves10.1194/jlr.R400001-JLR200
Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
resolves10.1016/j.jacc.2015.01.050
Relationship of Oxidized Phospholipids on Apolipoprotein B-100 to Cardiovascular Outcomes in Patients Treated With Intensive Versus Moderate Atorvastatin Therapy
resolves10.1016/j.jacc.2015.07.020
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis
resolves10.1161/hq1001.097027
Increased Transcription of IL-8 in Endothelial Cells Is Differentially Regulated by TNF-α and Oxidized Phospholipids
resolves10.1161/01.RES.87.6.516
Role for Peroxisome Proliferator-Activated Receptor α in Oxidized Phospholipid–Induced Synthesis of Monocyte Chemotactic Protein-1 and Interleukin-8 by Endothelial Cells
resolves10.1161/01.RES.0000207394.39249.fc
Identification of Prostaglandin E2 Receptor Subtype 2 As a Receptor Activated by OxPAPC
resolves10.4049/jimmunol.1002710
Human TMEM30a Promotes Uptake of Antitumor and Bioactive Choline Phospholipids into Mammalian Cells
resolves10.1126/science.aaf3036
An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells
resolves10.1038/nature01023
Protective role of phospholipid oxidation products in endotoxin-induced tissue damage
resolves10.1161/CIRCRESAHA.111.241869
Network for Activation of Human Endothelial Cells by Oxidized Phospholipids
resolves10.1084/jem.20150603
Endothelial NOTCH1 is suppressed by circulating lipids and antagonizes inflammation during atherosclerosis
resolves10.1161/01.RES.0000146030.53089.18
Role for Sterol Regulatory Element-Binding Protein in Activation of Endothelial Cells by Phospholipid Oxidation Products
resolves10.1146/annurev-immunol-031210-101405
The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
resolves10.1038/nri3452
Activation and regulation of the inflammasomes
resolves10.1371/journal.pone.0011765
Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
resolves10.1038/nature08938
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
resolves10.1038/ni.2639
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
resolves10.1161/CIRCULATIONAHA.113.002714
Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility
resolves10.1161/CIRCULATIONAHA.114.013675
Oxidative Stress Activates Endothelial Innate Immunity via Sterol Regulatory Element Binding Protein 2 (SREBP2) Transactivation of MicroRNA-92a
resolves10.1161/ATVBAHA.115.305282
Early Hyperlipidemia Promotes Endothelial Activation via a Caspase-1-Sirtuin 1 Pathway
resolves10.1016/S0092-8674(00)80213-5
The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor
resolves10.1371/journal.pone.0067532
Activation of Sterol Regulatory Element Binding Protein and NLRP3 Inflammasome in Atherosclerotic Lesion Development in Diabetic Pigs
resolves10.1126/science.aag0366
A lipid arsenal to control inflammation
resolves10.1182/blood.V99.1.199
Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca++/NFAT
resolves10.1016/j.cell.2015.12.057
NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria
resolves10.1074/jbc.M800352200
Oxidized Phospholipid Inhibition of Toll-like Receptor (TLR) Signaling Is Restricted to TLR2 and TLR4
resolves10.4049/jimmunol.0903594
Oxidized Phospholipids Are More Potent Antagonists of Lipopolysaccharide than Inducers of Inflammation
resolves10.1161/ATVBAHA.108.173799
Multi-Hit Inhibition of Circulating and Cell-Associated Components of the Toll-Like Receptor 4 Pathway by Oxidized Phospholipids
resolves10.1016/j.redox.2015.07.008
Antioxidant responses and cellular adjustments to oxidative stress
resolves10.1042/CS20150436
Nrf2 in health and disease: current and future clinical implications
resolves10.1161/CIRCRESAHA.109.215715
Identification of a Novel Macrophage Phenotype That Develops in Response to Atherogenic Phospholipids via Nrf2
resolves10.1161/CIRCRESAHA.108.176883
Nrf2 Regulates Antioxidant Gene Expression Evoked by Oxidized Phospholipids in Endothelial Cells and Murine Arteries In Vivo
resolves10.1161/01.ATV.0000153106.03644.a0
Oxidized Phospholipids Trigger Atherogenic Inflammation in Murine Arteries
resolves10.15252/emmm.201404702
Phospholipid oxidation generates potent anti‐inflammatory lipid mediators that mimic structurally related pro‐resolving eicosanoids by activating Nrf2
resolves10.1152/ajplung.00248.2014
Oxidized phospholipids protect against lung injury and endothelial barrier dysfunction caused by heat-inactivated <i>Staphylococcus aureus</i>
resolves10.1016/j.cellsig.2016.02.015
Dual role of vinculin in barrier-disruptive and barrier-enhancing endothelial cell responses
resolves10.1016/j.atherosclerosis.2013.06.005
Inhibition of monocyte chemotaxis by VB-201, a small molecule lecinoxoid, hinders atherosclerosis development in ApoE−/− mice
resolves10.1111/cei.12212
VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis
resolves10.1007/s10620-016-4159-5
Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis
resolves10.1016/j.immuni.2012.03.010
12/15-Lipoxygenase Orchestrates the Clearance of Apoptotic Cells and Maintains Immunologic Tolerance
resolves10.1194/jlr.M062539
Oxidized LDL signals through Rho-GTPase to induce endothelial cell stiffening and promote capillary formation
resolves10.1016/j.molmed.2016.05.006
Oxysterols in Metabolic Syndrome: From Bystander Molecules to Bioactive Lipids
resolves10.1038/nature10449
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress
resolves10.1016/j.freeradbiomed.2011.05.029
Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a
resolves10.4049/jimmunol.1303075
Scavenger Receptor Function of Mouse Fcγ Receptor III Contributes to Progression of Atherosclerosis in Apolipoprotein E Hyperlipidemic Mice
resolves10.1073/pnas.1604780113
Stabilin-1 expression defines a subset of macrophages that mediate tissue homeostasis and prevent fibrosis in chronic liver injury
resolves10.1194/jlr.M053256
Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine
resolves10.1074/jbc.M305460200
Carboxyethylpyrrole Protein Adducts and Autoantibodies, Biomarkers for Age-related Macular Degeneration
resolves10.1182/blood-2015-08-664300
Novel phosphatidylethanolamine derivatives accumulate in circulation in hyperlipidemic ApoE−/− mice and activate platelets via TLR2
resolves10.1038/nature09421
Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands
resolves10.1161/CIRCRESAHA.117.305925
Receptor-Mediated Mechanism Controlling Tissue Levels of Bioactive Lipid Oxidation Products
resolves10.1371/journal.pone.0088201
T Cells and Macrophages Responding to Oxidative Damage Cooperate in Pathogenesis of a Mouse Model of Age-Related Macular Degeneration
resolves10.1161/CIRCRESAHA.112.274241
Engagement of Platelet Toll-Like Receptor 9 by Novel Endogenous Ligands Promotes Platelet Hyperreactivity and Thrombosis
resolves10.1021/acs.chemrestox.6b00152
Efficient Quantitative Analysis of Carboxyalkylpyrrole Ethanolamine Phospholipids: Elevated Levels in Sickle Cell Disease Blood
resolves10.1161/CIRCULATIONAHA.116.020838
Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans
The 4 references without a DOI — listed, not checked
no DOI — not checkedMice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gram-negative bacterial infection
no DOI — not checkedCyclopentenone-containing oxidized phospholipids and their isoprostanes as pro-resolving mediators of inflammation
no DOI — not checkedBiological and pathophysiological roles of end-products of DHA oxidation
no DOI — not checkedMalondialdehyde epitopes as mediators of sterile inflammation
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.tem.2016.11.002"><img src="https://citestamp.com/citestamped/10.1016/j.tem.2016.11.002/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.tem.2016.11.002/badge.svg)](https://citestamp.com/citestamped/10.1016/j.tem.2016.11.002)